Volume | 17,907,783 |
|
|||||
News | (5) | ||||||
Day High | 1.37 | Low High |
|||||
Day Low | 1.28 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Ginkgo Bioworks Holdings Inc | DNA | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.30 | 1.28 | 1.37 | 1.36 | 1.33 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
24,198 | 17,907,783 | US$ 1.32 | US$ 23,624,941 | - | 1.12 - 2.545 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:58:34 | 1 | US$ 1.3499 | USD |
Ginkgo Bioworks Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
24.19B | 2.12B | - | 477.71M | -2.1B | -0.99 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Ginkgo Bioworks News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DNA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.29 | 1.44 | 1.28 | 1.36 | 20,919,692 | 0.06 | 4.65% |
1 Month | 1.28 | 1.59 | 1.2216 | 1.39 | 18,949,702 | 0.07 | 5.47% |
3 Months | 1.92 | 2.07 | 1.2216 | 1.55 | 18,884,834 | -0.57 | -29.69% |
6 Months | 1.77 | 2.545 | 1.2216 | 1.81 | 20,884,554 | -0.42 | -23.73% |
1 Year | 1.78 | 2.545 | 1.12 | 1.68 | 20,936,002 | -0.43 | -24.16% |
3 Years | 11.24 | 15.864 | 1.12 | 2.96 | 19,882,719 | -9.89 | -87.99% |
5 Years | 11.24 | 15.864 | 1.12 | 2.96 | 19,882,719 | -9.89 | -87.99% |
Ginkgo Bioworks Description
Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. |